Valuation Kobayashi Pharmaceutical Co., Ltd.

Stocks

4967

JP3301100008

Personal Products

Market Closed - 09:30:00 28/08/2026 +03 5-day change 1st Jan Change
5,690.00 JPY +0.18% Intraday chart for Kobayashi Pharmaceutical Co., Ltd. +0.99% +4.83%

Company Valuation: Kobayashi Pharmaceutical Co., Ltd.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 704,427 650,295 503,841 463,131 403,511 422,987 - -
Change - -7.68% -22.52% -8.08% -12.87% 4.83% - -
Enterprise Value (EV) 1 596,011 546,554 424,992 398,232 333,575 360,974 353,188 347,316
Change - -8.3% -22.24% -6.3% -16.24% 8.21% -2.16% -1.66%
P/E 35.8x 34.8x 25.3x 46x 110x 41.9x 31.2x 25.2x
PBR 3.59x 3.47x 2.47x 2.18x 1.92x 2.01x 1.96x 1.89x
PEG - 12.08x 7.7x -0.9x -1.7x 0x 0.9x 1.1x
Capitalization / Revenue 4.54x 3.91x 2.9x 2.8x 2.43x 2.45x 2.35x 2.27x
EV / Revenue 3.84x 3.29x 2.45x 2.4x 2.01x 2.09x 1.97x 1.86x
EV / EBITDA 19.3x 17.1x 13.3x 12.1x 14.1x 16.4x 13.1x 11.1x
EV / EBIT 22.9x 20.5x 16.5x 16x 22.4x 27.7x 20.2x 16.2x
EV / FCF 31.8x 31.1x -350x -29.2x 68.5x 24.8x 23.1x 20.2x
FCF Yield 3.15% 3.22% -0.29% -3.42% 1.46% 4.03% 4.33% 4.96%
Dividend per Share 2 83 90 101 102 104 106 109.5 114.3
Rate of return 0.92% 1% 1.49% 1.64% 1.92% 1.86% 1.92% 2.01%
EPS 2 252.4 259.6 268.2 135.4 49.19 135.8 182.4 225.4
Distribution rate 32.9% 34.7% 37.7% 75.3% 211% 78.1% 60% 50.7%
Net sales 1 155,252 166,258 173,455 165,600 165,742 172,322 179,620 186,639
EBITDA 1 30,900 32,027 31,837 32,800 23,600 21,965 26,990 31,262
EBIT 1 26,065 26,669 25,780 24,860 14,923 13,012 17,481 21,464
Net income 1 19,715 20,022 20,338 10,067 3,656 10,155 13,660 16,493
Net Debt 1 -108,416 -103,741 -78,849 -64,899 -69,936 -62,013 -69,799 -75,671
Reference price 2 9,040.00 9,030.00 6,790.00 6,230.00 5,428.00 5,690.00 5,690.00 5,690.00
Nbr of stocks (in thousands) 77,923 72,015 74,203 74,339 74,339 74,339 - -
Announcement Date 2/4/22 A 2/14/23 A 2/9/24 A 2/10/25 A 2/10/26 A - - -
1JPY in Million2JPY
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
41.91x2.09x16.43x1.86% 2.64B
20.94x4.04x14.73x3.06% 334B
18.62x2.79x12.3x3.43% 139B
24.68x3.69x15.52x2.34% 72.34B
41.7x6.72x29.15x2.21% 49.42B
34.87x2.65x14.51x1.56% 37.41B
20.16x2.82x11.74x4.4% 36.82B
23.64x1.73x11.04x2.15% 20.56B
21.2x1.38x8.96x1.24% 20.35B
16.22x1.55x8.89x3.27% 19.81B
Average 26.39x 2.95x 14.33x 2.55% 73.28B
Weighted average by Cap. 22.97x 3.60x 14.74x 2.92%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA



Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. 4967 Stock
  4. Valuation Kobayashi Pharmaceutical Co., Ltd.